MedMira Inc. (MMIRF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
As of 09:30AM EDT. Market open.
| Previous Close | 0.0600 |
| Open | 0.0600 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0600 - 0.0600 |
| 52 Week Range | 0.0121 - 0.2000 |
| Volume | |
| Avg. Volume | 1,095 |
| Market Cap | 42.104M |
| Beta (5Y Monthly) | 11.04 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0000 |
| Earnings Date | Jun 28, 2024 - Jul 02, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Simply Wall St.MedMira Second Quarter 2024 Earnings: CA$0.001 loss per share (vs CA$0.001 loss in 2Q 2023)
MedMira ( CVE:MIR ) Second Quarter 2024 Results Key Financial Results Revenue: CA$148.7k (down 13% from 2Q 2023). Net...
- ACCESSWIRE
MedMira Reports Second Quarter Results FY2024
HALIFAX, NS / ACCESSWIRE / April 1, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2024. Corporate update During Q2 FY2024, MedMira received the US FDA 510(k) clearance for the HIV-2 ...
ACCESSWIREMedMira Receives Canadian Patent for its Unique Quantitative Diagnostic System
HALIFAX, NS / ACCESSWIRE / March 13, 2024 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the receipt of a Canadian patent patent (number 2,949,634) for its new innovative and quantitative test system. This is in addition to the U.S. patent (number ...
© 2024 Yahoo. All rights reserved.